Recursion Pharmaceuticals, Inc. · NASDAQ:RXRX
BlackRock, Inc. reported a 8.50% stake in Recursion Pharmaceuticals, Inc. (Schedule 13G/A)
Event Jun 30, 2026 · Filed Jul 29, 2026
BlackRock, Inc. reported a 8.50% stake in Recursion Pharmaceuticals, Inc., 44,541,605 shares, as a passive investor on Jun 30, 2026. Filed Jul 29, 2026 (Schedule 13G/A).
- Stake
- 8.50%
- Shares
- 44,541,605
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 8.50% | 44,541,605 |
Source
Related
- Recursion Pharmaceuticals, Inc.
- BlackRock, Inc.
- Recursion Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · BlackRock, Inc. · Apr 24, 2026
- Schedule 13G/A · BlackRock, Inc. · Feb 5, 2025
- Form 4 · Borgeson Blake · Oct 7, 2026
- Form 4 · Hershberg Robert · Oct 7, 2026
- Form 4 · Dar Zavain · Oct 2, 2026
- Form 4 · Li Dean Y · Oct 2, 2026
- Form 4 · Taylor Ben R · Sep 16, 2026